Exelixis | Należności Handlowe



Trade Debtors Zmiana Data
Acadia Pharmaceuticals USD 104.7M 5.67M 2024-12
Agios Pharmaceuticals USD 4.11M 991K 2024-12
Amgen USD 6.78B 535M 2024-12
AstraZeneca USD 14.83B 1.28B 2024-12
Bayer EUR 12.5B 1.33B 2024-12
BioMarin Pharmaceutical USD 660.54M 117.01M 2024-12
Bristol-Myers Squibb USD 14.42B 471M 2024-12
Cytokinetics USD 16.65M 16.41M 2024-12
Eisai JPY 235.64B 40.42B 2024-12
Eli Lilly USD 13.28B 1.22B 2024-12
Exelixis USD 265.44M 4.27M 2025-01
Genmab DKK 6.69B 381M 2024-12
Glaxosmithkline GBP 7.32B 542M 2024-12
Incyte USD 853.15M 94.7M 2024-12
Ionis Pharmaceuticals USD 92.19M 74.26M 2024-12
MacroGenics USD 8.75M 2.56M 2024-09
Merck USD 11.12B 1.06B 2024-12
Moderna USD 592M 1.24B 2024-12
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 9B 854M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Sanofi 8.8B 2.24B 2024-06
Takeda JPY 735.06B 14.01B 2024-12
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Xencor USD 60.85M 50.64M 2024-12



Exelixis Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.